Previous studies have shown that activation of the Nur77/RXR heterodimer is responsible for reducing monocyte-mediated inflammation in the intestine [35] and that Nur77 has an important protective effect on the development of inflammatory bowel disease [36, 37]. Here, NR4A1 is linked to inflammatory bowel disease.